OBO_ID (LABEL):	CL_0000236 (B cell)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2409299	5/2008	S126-PMC2409299	['laboratory methods\nT-Lymphocyte (cd3+, Cd4+, Cd8+, B-Cell (Cd19+), and Natural Killer Cell (Cd56+) subpopulations were enumerated in whole Blood samples at Birth (Cord Blood) and at 8, 16 and 52 weeks of age by flow cytometry (facscalibur, beckton dickinson uk ltd, oxford, uk) using appropriate isotypic controls (cyto-stat, beckman-coulter international s.a., nyon, switzerland).']	N/A	N/A	[('CL_0000084', 'T cell', 19, 'T-lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 39, 'CD4'), ('PR_000005170', 'CD37 molecule', 45, 'CD8'), ('CL_0000236', 'B cell', 51, 'B-cell'), ('PR_000001309', 'CD70 molecule', 59, 'CD19'), ('CL_0000623', 'natural killer cell', 71, 'natural killer cell'), ('PR_000001309', 'CD70 molecule', 92, 'CD56'), ('UBERON_0000178', 'blood', 139, 'blood'), ('GO_0007567', 'parturition', 156, 'birth'), ('UBERON_0002240', 'spinal cord', 163, 'cord'), ('UBERON_0000178', 'blood', 168, 'blood')]
PMC3029215	1/2011	S157-PMC3029215	['*affymetrix idgene namefdrfold change (aa vs ca)welch t-test ( p )Gene description205048_s_at "psph"‡04.084 × 10-9phosphoserine phosphatase212777_at Sos1 01.361 × 10-7son of Sevenless Homolog 1202203_s_at Amfr 01.724 × 10-6autocrine motility factor receptor204379_s_at Fgfr3 01.242 × 10-5fibroblast growth factor receptor 3219417_s_at flj20014 00.916 × 10-5chromosome 17 Open Reading Frame 59208416_s_at Sptb 00.911.9 × 10-4spectrin, beta, Erythrocytic206763_At Fkbp6 00.906 × 10-5fk506 binding Partner 6, 36 kda202253_s_at Dnm2 00.902.3 × 10-4Dynamin 2214380_at Prpf31 00.909 × 10-5precursor Mrna-Processing Factor 31, s. cerevisiae, Homolog of213209_at taf6l 00.898 × 10-7taf6-like rna polymerase ii, P300/6cbp associated factor (Pcaf), associated factor, p65216204_at arvcf 00.894 × 10-6armadillo repeat Gene deletes in velocardiofacial syndrome213585_s_at Pdcd2 00.893 × 10-5programmed Cell Death 2201572_x_at dctd 00.892.1 × 10-4Deoxycytidylate deaminase203589_s_at Tfdp2 00.893.3 × 10-4transcription factor Dp-2 (E2F Dimerization Partner 2)211096_at Pbx2 00.883 × 10-6pre B-Cell Leukemia Transcription Factor 2215844_at Tnpo2 00.888 × 10-5transportin 2206182_at Znf134 00.882.3 × 10-4zinc finger protein 134219125_s_at loc55974 00.872 × 10-5Stromal Cell protein201557_at Vamp2 00.876 × 10-5vesicle-Associated Membrane Protein 2 (Synaptobrevin2)202700_s_at kiaa0792 00.871.3 × 10-4transmembrane protein 63a209009_at esd 00.872 × 10-4esterase d200076_s_at mgc2749 00.863 × 10-5hypothetical protein mgc2749207415_at Pla2R1 00.862 × 10-5phospholipase A2 Receptor 1, 180 kda222129_at c2orf17 00.861.6 × 10-4chromosome x Open Reading Frame 17202646_s_at d1s155e 00.851.1 × 10-4cold-shock Domain-containing e1, rna-binding; csde1222199_s_at bin3 00.857 × 10-5bridging integrator 3219939_s_at d1s155e 00.821 × 10-4cold-shock Domain-containing e1, rna-binding; csde1203538_at camlg 00.827 × 10-4Calcium-Modulating cyclophilin ligand208757_at hsgp25l2g 00.811 × 10-6gp25l2 protein218354_at loc51693 00.813.5 × 10-4hematopoietic Stem/progenitor Cells 176204340_at Cxorf12 00.772 × 10-4chromosome x Open Reading Frame 12219599_at Eif4B 00.764 × 10-5eukaryotic Translation Initiation Factor 4B\n*this table shows only those Genes that meet the very high stringency level of fdr = 0 by sam (significance analysis of microarray).']	N/A	N/A	[('SO_0000704', 'gene', 66, 'Gene'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 149, 'SOS1'), ('PR_000014462', 'squamous cell carcinoma antigen recognized by T-cells 3', 174, 'Sevenless Homolog'), ('PR_000003920', 'retinal dehydrogenase 1', 205, 'AMFR'), ('PR_000001450', 'fibroblast growth factor receptor 3', 269, 'FGFR3'), ('SO_0000236', 'ORF', 371, 'Open Reading Frame'), ('PR_000015599', 'protein SPT2', 404, 'SPTB'), ('CL_0002638', 'bronchioalveolar stem cell', 440, 'Erythrocytic206763_at'), ('PR_000007544', 'peptidyl-prolyl cis-trans isomerase FKBP8', 462, 'FKBP6'), ('PR_000014368', 'RuvB-like 1', 495, 'Partner 6'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 524, 'DNM2'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 543, '4Dynamin'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 563, 'PRPF31'), ('GO_0006397', 'mRNA processing', 593, 'mRNA-processing'), ('PR_000010299', 'mediator of RNA polymerase II transcription subunit 27', 593, 'mRNA-processing Factor 31'), ('SO_0000853', 'homologous_region', 635, 'Homolog'), ('PR_000005450', 'chromatin accessibility complex protein 1', 703, 'p300'), ('PR_000012443', 'cyclin-dependent kinase 18', 732, 'PCAF'), ('SO_0000704', 'gene', 807, 'Gene'), ('PR_000012493', 'pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial', 860, 'PDCD2'), ('GO_0008219', 'cell death', 890, 'Cell Death'), ('CHEBI_34678', 'Di-n-hexyl phthalate', 933, '4Deoxycytidylate'), ('PR_000016272', 'transcription factor EB', 971, 'TFDP2'), ('PR_000006664', 'dipeptidyl peptidase 9', 1013, 'DP-2'), ('PR_000007140', 'epsin-3', 1019, 'E2F Dimerization Partner 2'), ('GO_0006260', 'DNA replication', 1023, 'Dimerization'), ('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 1056, 'PBX2'), ('CL_0000236', 'B cell', 1078, 'B-cell'), ('PR_000004712', 'breakpoint cluster region protein', 1078, 'B-cell Leukemia Transcription Factor'), ('UBERON_0004608', 'rib 9', 1078, 'B-'), ('PR_000016505', 'troponin I, fast skeletal muscle', 1126, 'TNPO2'), ('PR_000017770', 'zinc finger protein 234', 1168, 'ZNF134'), ('CL_0000848', 'microvillous olfactory receptor neuron', 1246, '5Stromal Cell'), ('PR_000017269', 'ventral anterior homeobox 2', 1277, 'VAMP2'), ('PR_000004806', 'bromodomain-containing protein 2', 1303, '-associated Membrane Protein 2'), ('GO_0016020', 'membrane', 1315, 'Membrane'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 1335, 'Synaptobrevin2'), ('PR_000012809', 'cytosolic phospholipase A2 zeta', 1519, 'PLA2R1'), ('PR_000001194', 'beta-3 adrenergic receptor', 1553, 'A2 Receptor 1'), ('SO_0000236', 'ORF', 1621, 'Open Reading Frame'), ('SO_0000417', 'polypeptide_domain', 1688, 'Domain'), ('SO_0000417', 'polypeptide_domain', 1823, 'Domain'), ('CHEBI_50315', 'chloronium', 1891, '4Calcium'), ('GO_0065007', 'biological regulation', 1900, 'modulating'), ('CL_0000499', 'stromal cell', 2024, 'Stem ... Cells'), ('PR_000030433', 'CKLF-like MARVEL transmembrane domain-containing protein 2', 2059, 'CXorf12'), ('SO_0000236', 'ORF', 2093, 'Open Reading Frame'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 2124, 'EIF4B'), ('GO_0006415', 'translational termination', 2154, 'Translation Initiation'), ('PR_000016339', 'T-cell immunoglobulin and mucin domain-containing protein 4', 2154, 'Translation Initiation Factor 4B'), ('SO_0000704', 'gene', 2216, 'genes')]
PMC3277098	12/2011	S53-PMC3277098	['this network (the galt) is the largest Immune “Organ” of the body and comprises distinct Tissues (such as the Peyer’S Patches and Mesenteric Lymph Nodes) as well as a vast array of migrating cells that passage through the local Tissues (such as Dc, B Cells, Effector T Cells and a range of Regulatory populations).']	N/A	N/A	[('UBERON_0002405', 'immune system', 39, 'immune'), ('UBERON_0000062', 'organ', 47, 'organ'), ('UBERON_0000479', 'tissue', 89, 'tissues'), ('UBERON_0002033', 'arrector muscle of hair', 110, 'Peyer’s patches'), ('UBERON_0000080', 'mesonephros', 130, 'mesenteric'), ('UBERON_0000029', 'lymph node', 141, 'lymph nodes'), ('UBERON_0000479', 'tissue', 228, 'tissues'), ('CL_0000784', 'plasmacytoid dendritic cell', 245, 'DC'), ('CL_0000236', 'B cell', 249, 'B cells'), ('CHEBI_35224', 'effector', 258, 'effector'), ('CL_0000911', 'effector T cell', 258, 'effector T cells'), ('GO_0065007', 'biological regulation', 290, 'regulatory')]
PMC3347028	3/2012	S74-PMC3347028	['the Vitamin D receptor (vdr) is found on Activated (but not resting) Human T- and B-Lymphocytes.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('CL_0002627', 'mature astrocyte', 41, 'activated'), ('NCBITaxon_9606', 'Homo sapiens', 69, 'human'), ('CL_0000918', 'Tc2 cell', 75, 'T- ...'), ('CL_0000236', 'B cell', 82, 'B-lymphocytes')]
PMC3415261	7/2012	S57-PMC3415261	['in Rats, B Lymphocytes constitute the earliest occurring population in the Spleen after Birth (figure 1(a)), and during the Suckling period these cells present an immature phenotype characterized by low Surface Igm Expression [24].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CL_0000236', 'B cell', 9, 'B lymphocytes'), ('UBERON_0002106', 'spleen', 75, 'spleen'), ('GO_0007567', 'parturition', 88, 'birth'), ('GO_0001967', 'suckling behavior', 124, 'suckling'), ('GO_0009986', 'cell surface', 203, 'surface'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 211, 'IgM'), ('GO_0010467', 'gene expression', 215, 'expression')]
PMC3415261	7/2012	S59-PMC3415261	['data from Humans report that B Cells appear in the fetal Spleen together with Liver, Bone Marrow, and Lymph Nodes at 7-8 weeks of Gestation, and these B Cells possess an immature phenotype with no Surface Immunoglobulins but Cytoplasmic Igm [26].']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 10, 'humans'), ('CL_0000236', 'B cell', 29, 'B cells'), ('UBERON_0002106', 'spleen', 57, 'spleen'), ('UBERON_0002107', 'liver', 78, 'liver'), ('UBERON_0002371', 'bone marrow', 85, 'bone marrow'), ('UBERON_0000029', 'lymph node', 102, 'lymph nodes'), ('GO_0007565', 'female pregnancy', 130, 'gestation'), ('CL_0000236', 'B cell', 151, 'B cells'), ('GO_0097420', 'skein-like inclusion', 197, 'surface immunoglobulins'), ('GO_0005737', 'cytoplasm', 225, 'cytoplasmic'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 237, 'IgM')]
PMC3415261	7/2012	S112-PMC3415261	['Adult Rat lpls show a predominance of Cd4+ T Cells, followed by B Lymphocytes, a small proportion of Cd8+ cells and also a minor population of Nk Cells (figure 2(b)) [31,68].']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 6, 'rat'), ('PR_000001204', 'C-C chemokine receptor type 8', 38, 'CD4'), ('CL_0000084', 'T cell', 43, 'T cells'), ('CL_0000236', 'B cell', 64, 'B lymphocytes'), ('PR_000005170', 'CD37 molecule', 101, 'CD8'), ('CL_0000623', 'natural killer cell', 143, 'NK cells'), ('GO_0005634', 'nucleus', 143, 'NK')]
PMC3415261	7/2012	S148-PMC3415261	['later, around weaning, B Cells expand, and afterwards and in Adult Life, Cd4+ Lpl are the most common [31].']	N/A	N/A	[('CL_0000236', 'B cell', 23, 'B cells'), ('UBERON_0000113', 'post-juvenile adult stage', 61, 'adult life'), ('PR_000001204', 'C-C chemokine receptor type 8', 73, 'CD4'), ('PR_000009880', 'Lon protease, mitochondrial', 78, 'LPL')]
PMC3553086	1/2013	S191-PMC3553086	['briefly, whole Blood, Peripheral Blood Mononuclear Cells (pbmc), Cd4+T Cells, Cd8+T-Cells, Cd56+Nk Cells, Cd19+B Cells, cd14+Monocytes, Granulocytes, Neutrophils and Eosinophils were isolated.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('CL_0000111', 'peripheral neuron', 22, 'peripheral blood'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CL_0000226', 'single nucleate cell', 39, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 39, 'mononuclear'), ('PR_000001204', 'C-C chemokine receptor type 8', 65, 'CD4'), ('CL_0000084', 'T cell', 69, 'T cells'), ('PR_000005170', 'CD37 molecule', 78, 'CD8'), ('CL_0000084', 'T cell', 82, 'T-cells'), ('PR_000001309', 'CD70 molecule', 91, 'CD56'), ('CL_0000623', 'natural killer cell', 96, 'NK cells'), ('GO_0005634', 'nucleus', 96, 'NK'), ('PR_000001309', 'CD70 molecule', 106, 'CD19'), ('CL_0000236', 'B cell', 111, 'B cells'), ('CL_0000576', 'monocyte', 125, 'monocytes'), ('CL_0000094', 'granulocyte', 136, 'granulocytes'), ('CL_0000775', 'neutrophil', 150, 'neutrophils'), ('CL_0000771', 'eosinophil', 166, 'eosinophils')]
PMC3553086	1/2013	S193-PMC3553086	['magnetic-Activated Cell sorting (macs, miltenyi biotech, germany) was used to obtain T Cells, B Cells, Monocytes, and Nk Cells from the pbmc:s and Neutrophils and Eosinophils from the Granulocyte containing pellet.']	N/A	N/A	[('CL_0000161', 'acid secreting cell', 9, 'activated cell'), ('CL_0000084', 'T cell', 85, 'T cells'), ('CL_0000236', 'B cell', 94, 'B cells'), ('CL_0000576', 'monocyte', 103, 'monocytes'), ('CL_0000623', 'natural killer cell', 118, 'NK cells'), ('GO_0005634', 'nucleus', 118, 'NK'), ('CL_0000775', 'neutrophil', 147, 'neutrophils'), ('CL_0000771', 'eosinophil', 163, 'eosinophils'), ('CL_0000094', 'granulocyte', 184, 'granulocyte')]
PMC3613945	2/2013	S68-PMC3613945	['the stepwise Glycohydrolysis promoted by T and B Cells leads to loss of the o -glycosylated Oligosaccharide Moiety in the dbp peptide, transforming it into a potent Macrophage activating factor (gc-maf)61,62.']	N/A	N/A	[('GO_0006096', 'glycolytic process', 13, 'glycohydrolysis'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 41, 'T ...'), ('CL_0000236', 'B cell', 47, 'B cells'), ('CHEBI_50699', 'oligosaccharide', 92, 'oligosaccharide'), ('CHEBI_29357', 'methanediyl', 108, 'moiety'), ('CL_0000235', 'macrophage', 165, 'macrophage')]
PMC3613945	2/2013	S283-PMC3613945	['rheumatic fever\nrheumatic fever is a systemic inflammatory illness characterized by excessive B Cell activity leading to an over-Production Of Antibody to group a streptococcus.']	N/A	N/A	[('CL_0000236', 'B cell', 94, 'B cell'), ('GO_0019230', 'proprioception', 129, 'production of antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 143, 'antibody')]
PMC3635901	4/2013	S26-PMC3635901	['by contrast, self-reactive Antibodies against self-reactive or cross-reactive dna co-engage Antigen receptors and tlrs, leading to a continuous activation of these auto-reactive B Cells and the development of Autoimmune disease [12].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 27, 'antibodies'), ('CHEBI_59132', 'antigen', 92, 'antigen'), ('CL_0000236', 'B cell', 178, 'B cells'), ('UBERON_0001442', 'skeleton of manus', 209, 'autoimmune')]
PMC3728489	7/2013	S34-PMC3728489	['the remaining maternal Decidua is comprised of Macrophages (cd 209+), while T-Cells, Dendritic Cells and specialized B Cells are scarce (chazara et al.,2011; erlebacher,2013).']	N/A	N/A	[('UBERON_0002450', 'decidua', 23, 'decidua'), ('CL_0000235', 'macrophage', 47, 'macrophages'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 63, '209'), ('CL_0000084', 'T cell', 76, 'T-cells'), ('CL_0000451', 'dendritic cell', 85, 'dendritic cells'), ('CL_0000236', 'B cell', 117, 'B cells')]
PMC3773919	9/2013	S161-PMC3773919	['administration of the Probiotics Mixture induced both T-Cells and B-Cells hyporesponsiveness and downregulated th1, th2, and th17 cytokines [81,83].']	N/A	N/A	[('CHEBI_26346', 'prostaglandins J', 22, 'probiotics'), ('CHEBI_60004', 'mixture', 33, 'mixture'), ('CL_0000084', 'T cell', 54, 'T-cells'), ('CL_0000236', 'B cell', 66, 'B-cells')]
PMC3907150	1/2014	S70-PMC3907150	['female carriers of agammaglobulinemia, an x-linked Immune deficiency, exhibit non-random xci in B Cell Lymphocytes [48], and female carriers of wiskott-aldrich syndrome exhibit non-random inactivation in all Blood Cell lineages [49].']	N/A	N/A	[('UBERON_0002405', 'immune system', 51, 'immune'), ('CL_0000236', 'B cell', 96, 'B cell lymphocytes'), ('CL_0000081', 'blood cell', 208, 'blood cell'), ('UBERON_0000178', 'blood', 208, 'blood')]
PMC3937977	2/2014	S103-PMC3937977	['the fetal T-Cell (and B-Cell) Development begins at the end of the first trimester, with a rapid expansion of cell numbers through early childhood.']	N/A	N/A	[('CL_0000084', 'T cell', 10, 'T-cell'), ('GO_0042092', 'type 2 immune response', 10, 'T-cell ...'), ('CL_0000236', 'B cell', 22, 'B-cell'), ('GO_0002326', 'B cell lineage commitment', 22, 'B-cell ... development')]
PMC4143239	8/2014	S172-PMC4143239	['Acquired Immunity\nacquired Immunity is characterized by specialized Cellular and Antibody-Mediated Immune Responses, generated by T- and B-Lymphocytes reacting with high specificity towards pathogens and creating long-Lasting Immunological Memory.']	N/A	N/A	[('GO_0006914', 'autophagy', 0, 'Acquired'), ('GO_0007566', 'embryo implantation', 9, 'immunity'), ('GO_0007566', 'embryo implantation', 27, 'immunity'), ('GO_0000911', 'cytokinesis by cell plate formation', 68, 'cellular ... -mediated immune responses'), ('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibody'), ('UBERON_0002405', 'immune system', 99, 'immune'), ('CL_0000918', 'Tc2 cell', 130, 'T- ...'), ('CL_0000236', 'B cell', 137, 'B-lymphocytes'), ('GO_0007568', 'aging', 217, '-lasting'), ('GO_0007566', 'embryo implantation', 226, 'immunological'), ('GO_0007613', 'memory', 240, 'memory')]
PMC4155824	8/2014	S194-PMC4155824	['the chromosomal dna of lgg and derived odns were also shown to be strong in vivo inducers of Murine B Cell Proliferation and were able to stimulate th1 immunity in Murine Splenocyte Cells [86].']	N/A	N/A	[('NCBITaxon_39107', 'Murinae', 93, 'murine'), ('CL_0000236', 'B cell', 100, 'B cell'), ('GO_0042100', 'B cell proliferation', 100, 'B cell proliferation'), ('NCBITaxon_39107', 'Murinae', 164, 'murine'), ('CL_0000214', 'synovial cell', 171, 'splenocyte cells')]
PMC4161853	8/2014	S16-PMC4161853	['it is also in the Spleen where a large population of naïve B Cells produced in the Bone Marrow matures into Memory B Cells.']	N/A	N/A	[('UBERON_0002106', 'spleen', 18, 'spleen'), ('CL_0000236', 'B cell', 59, 'B cells'), ('UBERON_0002371', 'bone marrow', 83, 'bone marrow'), ('CL_0000313', 'serous secreting cell', 108, 'memory'), ('GO_0007613', 'memory', 108, 'memory'), ('CL_0000236', 'B cell', 115, 'B cells')]
PMC4161853	8/2014	S28-PMC4161853	['next to the pals are the B Cell follicles.']	N/A	N/A	[('CL_0000236', 'B cell', 25, 'B cell')]
PMC4161853	8/2014	S29-PMC4161853	['together, pals and B Cell follicles constitute the White Pulp Of the Spleen (Wp).']	N/A	N/A	[('CL_0000236', 'B cell', 19, 'B cell'), ('UBERON_0001959', 'white pulp of spleen', 51, 'white pulp of ... spleen'), ('UBERON_0002828', 'ventral cochlear nucleus', 77, 'WP')]
PMC4161853	8/2014	S35-PMC4161853	['to accomplish its functions, the Spleen encompasses the following Anatomic subunits (figure\xa01): (1) the White Pulp (Wp), containing T Cell zones (Periarteriolar Lymphoid Sheath (Pals)) and B Cell follicles, where the Adaptive Immune Response takes place; (2) the Marginal Zone (Mz) containing Macrophages, Dendritic Cells (Dcs), Natural Killer T (Nkt) Cells (in Mice), B Cell-Helper Neutrophils (nbh), Innate Lymphoid Cells type 3 (Ilc3), Cd4+T Lymphocytes, mz B Cells and Memory B Cells, where Ti-1 and Ti-2 responses take place; (3) the Perifollicular Zone (Pfz), separating the Mz from the Red Pulp (Rp) and containing Rbcs, Pericapillary Macrophages, nbh,and Ilc3; (4) the rp-containing Macrophages, Dcs, nbh, Plasmablasts, being the place where Rbcs are efficiently filtered from the circulation and where Reticulocytes mature [9,10,13–16].']	N/A	N/A	[('UBERON_0002106', 'spleen', 33, 'spleen'), ('UBERON_0001062', 'anatomical entity', 66, 'anatomic'), ('UBERON_0001959', 'white pulp of spleen', 104, 'white pulp'), ('UBERON_0002828', 'ventral cochlear nucleus', 116, 'WP'), ('CL_0000084', 'T cell', 132, 'T cell'), ('UBERON_0001960', 'periarterial lymphatic sheath', 146, 'periarteriolar lymphoid sheath'), ('UBERON_0001960', 'periarterial lymphatic sheath', 178, 'PALS'), ('CL_0000236', 'B cell', 189, 'B cell'), ('GO_0002250', 'adaptive immune response', 217, 'adaptive immune response'), ('UBERON_0002405', 'immune system', 226, 'immune'), ('UBERON_3010452', 'non-involuting marginal zone', 263, 'marginal zone'), ('UBERON_2005031', 'dorsal longitudinal vein', 278, 'MZ'), ('CL_0000235', 'macrophage', 293, 'macrophages'), ('CL_0000451', 'dendritic cell', 306, 'dendritic cells'), ('CL_0000990', 'conventional dendritic cell', 323, 'DCs'), ('CL_0000623', 'natural killer cell', 329, 'natural killer T ...'), ('CL_0000820', 'B-1a B cell', 347, 'NKT ... cells'), ('NCBITaxon_10088', 'Mus <genus>', 362, 'mice'), ('CL_0000236', 'B cell', 369, 'B cell'), ('CL_0000546', 'T-helper 2 cell', 376, 'helper neutrophils'), ('CL_0002486', 'strial intermediate cell', 402, 'innate lymphoid cells'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 432, 'ILC3'), ('PR_000001204', 'C-C chemokine receptor type 8', 439, 'CD4'), ('CL_0000084', 'T cell', 443, 'T lymphocytes'), ('CL_0000236', 'B cell', 461, 'B cells'), ('CL_0000313', 'serous secreting cell', 473, 'memory'), ('GO_0007613', 'memory', 473, 'memory'), ('CL_0000236', 'B cell', 480, 'B cells'), ('PR_000016499', 'poly [ADP-ribose] polymerase tankyrase-2', 495, 'TI-1'), ('PR_000016499', 'poly [ADP-ribose] polymerase tankyrase-2', 504, 'TI-2'), ('UBERON_0003069', 'otic placode', 539, 'perifollicular zone'), ('UBERON_0009133', 'pleuroperitoneal membrane', 560, 'PFz'), ('UBERON_2005031', 'dorsal longitudinal vein', 581, 'MZ'), ('UBERON_0001250', 'red pulp of spleen', 593, 'red pulp'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 603, 'RP'), ('CL_0000232', 'erythrocyte', 622, 'RBCs'), ('CL_0000474', 'pericardial nephrocyte', 628, 'pericapillary macrophages'), ('UBERON_0018382', 'second instar larva', 628, 'pericapillary'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 663, 'ILC3'), ('CL_0000235', 'macrophage', 691, 'macrophages'), ('CL_0000990', 'conventional dendritic cell', 704, 'DCs'), ('CL_0000058', 'chondroblast', 714, 'plasmablasts'), ('CL_0000232', 'erythrocyte', 750, 'RBCs'), ('CL_0000558', 'reticulocyte', 811, 'reticulocytes')]
PMC4161853	8/2014	S39-PMC4161853	['penicilli have different possible ends (figure\xa01): (a) and (b) the Mz at different points; (c) Penicilli can enter the Mz and curved to end into the B Cell follicle; (d) they could reach the Rp and curve back to the external border of the Mz; (e) or they could drain directly into the Pfz and the Rp.']	N/A	N/A	[('UBERON_2005031', 'dorsal longitudinal vein', 67, 'MZ'), ('CHEBI_17334', 'penicillin', 95, 'penicilli'), ('UBERON_2005031', 'dorsal longitudinal vein', 119, 'MZ'), ('CL_0000236', 'B cell', 149, 'B cell'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 191, 'RP'), ('UBERON_2005031', 'dorsal longitudinal vein', 239, 'MZ'), ('UBERON_0009133', 'pleuroperitoneal membrane', 285, 'PFz'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 297, 'RP')]
PMC4161853	8/2014	S53-PMC4161853	['it also produces changes in the Adaptive Immune System, altering B Cell populations [24–26] and the response to certain vaccines [27].']	N/A	N/A	[('GO_0051866', 'general adaptation syndrome', 32, 'adaptive immune system'), ('UBERON_0002405', 'immune system', 41, 'immune system'), ('CL_0000236', 'B cell', 65, 'B cell')]
PMC4161853	8/2014	S104-PMC4161853	['mz B Cells are decreased in children with malaria\nas aforementioned, one of the Anatomic subunits of the Spleen Tissue is the Mz.']	N/A	N/A	[('CL_0000236', 'B cell', 3, 'B cells'), ('UBERON_0001062', 'anatomical entity', 80, 'anatomic'), ('UBERON_0002106', 'spleen', 105, 'spleen'), ('UBERON_0000479', 'tissue', 112, 'tissue'), ('UBERON_2005031', 'dorsal longitudinal vein', 126, 'MZ')]
PMC4161853	8/2014	S106-PMC4161853	['most of the Arterial Blood that enters the Spleen runs through the Mz inhabited by a special set of cells, such as Macrophages Expressing unique combinations of pattern recognition receptors, as well as Mz B Cells that can be readily activated [19].']	N/A	N/A	[('UBERON_0001637', 'artery', 12, 'arterial'), ('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0002106', 'spleen', 43, 'spleen'), ('UBERON_2005031', 'dorsal longitudinal vein', 67, 'MZ'), ('CL_0000235', 'macrophage', 115, 'macrophages'), ('GO_0010467', 'gene expression', 127, 'expressing'), ('CL_0000485', 'mucosal type mast cell', 203, 'MZ'), ('CL_0000236', 'B cell', 206, 'B cells')]
PMC4161853	8/2014	S107-PMC4161853	['mz B Cells are a distinct B Cell lineage [79] with a unique Surface phenotype, Expressing polyreactive Igm (B Cell Receptor: Bcr), Igd, Cd1C, Cd35 (Complement Receptor 1 (Cr1)), Cd21 (Complement Receptor 2 (Cr2)), Cd27, high levels of toll-like receptors (tlr), Mhc Class Ii, and taci (an Ig-inducing receptor) [13,80].']	N/A	N/A	[('CL_0000236', 'B cell', 3, 'B cells'), ('CL_0000236', 'B cell', 26, 'B cell'), ('GO_0009986', 'cell surface', 60, 'surface'), ('GO_0010467', 'gene expression', 79, 'expressing'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 103, 'IgM'), ('CL_0000236', 'B cell', 108, 'B cell'), ('PR_000001295', 'CAMPATH-1 antigen', 108, 'B cell receptor'), ('PR_000004760', 'bleomycin hydrolase', 125, 'BCR'), ('GO_0071735', 'IgG immunoglobulin complex', 131, 'IgD'), ('PR_000001309', 'CD70 molecule', 136, 'CD1c'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 142, 'CD35'), ('PR_000001200', 'C-C chemokine receptor type 4', 148, 'complement receptor 1'), ('PR_000005874', 'cysteine-rich protein 2', 171, 'CR1'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 178, 'CD21'), ('PR_000001200', 'C-C chemokine receptor type 4', 184, 'complement receptor 2'), ('PR_000005890', 'crooked neck-like protein 1', 207, 'CR2'), ('PR_000001309', 'CD70 molecule', 214, 'CD27'), ('GO_0042613', 'MHC class II protein complex', 262, 'MHC class II'), ('GO_0071735', 'IgG immunoglobulin complex', 289, 'Ig')]
PMC4161853	8/2014	S108-PMC4161853	['through the dual binding of Antigens to the bcr and tlr, mz B Cells are promptly activated, undergoing Ig class Switching and somatic hyper-mutation in a T Cell-independent manner.']	N/A	N/A	[('CHEBI_59132', 'antigen', 28, 'antigens'), ('CL_0000236', 'B cell', 60, 'B cells'), ('GO_0071735', 'IgG immunoglobulin complex', 103, 'Ig'), ('GO_0036268', 'swimming', 112, 'switching'), ('CL_0000084', 'T cell', 154, 'T cell')]
PMC4161853	8/2014	S110-PMC4161853	['when only the bcr is stimulated, mz B Cells migrate to the T Cell zone to develop a T Cell-dependent Antibody response.']	N/A	N/A	[('CL_0000236', 'B cell', 36, 'B cells'), ('CL_0000084', 'T cell', 59, 'T cell'), ('CL_0000084', 'T cell', 84, 'T cell'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody')]
PMC4161853	8/2014	S111-PMC4161853	['through taci receptors, mz B Cells receive assistance by the nbhto produce Igm and for class switching from Igm to Igg or Iga in a T Cell-independent manner [16].']	N/A	N/A	[('CL_0000236', 'B cell', 27, 'B cells'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 75, 'IgM'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 108, 'IgM'), ('GO_0071735', 'IgG immunoglobulin complex', 115, 'IgG'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 122, 'IgA'), ('CL_0000084', 'T cell', 131, 'T cell')]
PMC4161853	8/2014	S121-PMC4161853	['as explained, the Development Of peripheral B Cells takes place during infancy.']	N/A	N/A	[('GO_0048468', 'cell development', 18, 'development of ... B cells'), ('CL_0000236', 'B cell', 44, 'B cells')]
PMC4161853	8/2014	S177-PMC4161853	['the White Pulp (Periarteriolar Lymphoid Sheaths (Pals) and B Cell follicle) and the Marginal Zone (Mz) do not show atrophy and preserve their function.']	N/A	N/A	[('UBERON_0001959', 'white pulp of spleen', 4, 'white pulp'), ('UBERON_0001179', 'peritoneal cavity', 16, 'periarteriolar'), ('UBERON_0000444', 'lymphoid follicle', 31, 'lymphoid sheaths'), ('UBERON_0001960', 'periarterial lymphatic sheath', 49, 'PALS'), ('CL_0000236', 'B cell', 59, 'B cell'), ('UBERON_3010452', 'non-involuting marginal zone', 84, 'marginal zone'), ('UBERON_2005031', 'dorsal longitudinal vein', 99, 'MZ')]
PMC4161853	8/2014	S183-PMC4161853	['Ca: Central Arteriole; Vs: Venous Sinuses; Rbc: Red Blood Cell; irbc: infected Rbc; Mø: Macrophages; Pc: Plasma Cells; Dc: Dendritic Cells; Mz B Cells: Marginal Zone B Cells.']	N/A	N/A	[('UBERON_2005019', 'efferent lamellar arteriole', 0, 'CA'), ('UBERON_2000474', 'intercalar', 4, 'central arteriole'), ('UBERON_0005432', 'aortic sac', 23, 'VS'), ('UBERON_0002463', 'muscle of posterior compartment of hindlimb stylopod', 27, 'venous sinuses'), ('CL_0000232', 'erythrocyte', 43, 'RBC'), ('CL_0000232', 'erythrocyte', 48, 'red blood cell'), ('UBERON_0000178', 'blood', 52, 'blood'), ('CL_0000232', 'erythrocyte', 79, 'RBC'), ('CL_0000485', 'mucosal type mast cell', 84, 'MØ'), ('CL_0000235', 'macrophage', 88, 'macrophages'), ('CL_0000696', 'PP cell', 101, 'PC'), ('CL_0000786', 'plasma cell', 105, 'plasma cells'), ('CL_0000784', 'plasmacytoid dendritic cell', 119, 'DC'), ('CL_0000451', 'dendritic cell', 123, 'dendritic cells'), ('UBERON_2005031', 'dorsal longitudinal vein', 140, 'MZ'), ('CL_0000236', 'B cell', 143, 'B cells'), ('CL_0000845', 'marginal zone B cell of spleen', 152, 'marginal zone'), ('CL_0000236', 'B cell', 166, 'B cells')]
PMC4161853	8/2014	S198-PMC4161853	['Rbc: Red Blood Cell; Bm: Bone Marrow; mz B Cells: Marginal Zone B Cells; Mø: Macrophages; ibi: invasive bacterial infection; crp: complement Regulatory proteins.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 0, 'RBC'), ('CL_0000232', 'erythrocyte', 5, 'red blood cell'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0005401', 'cerebral hemisphere gray matter', 21, 'BM'), ('UBERON_0002371', 'bone marrow', 25, 'bone marrow'), ('CL_0002492', 'strial marginal cell', 30, 'marrow'), ('CL_0000236', 'B cell', 41, 'B cells'), ('CL_0000845', 'marginal zone B cell of spleen', 50, 'marginal zone'), ('CL_0000236', 'B cell', 64, 'B cells'), ('CL_0000485', 'mucosal type mast cell', 73, 'MØ'), ('CL_0000235', 'macrophage', 77, 'macrophages'), ('GO_0065007', 'biological regulation', 141, 'regulatory')]
PMC4161853	8/2014	S215-PMC4161853	['furthermore, Intestinal Epithelial Cells send signals through ra to Dcs in the Gut Lamina Propria promoting Iga Class Switching in local B Cells [118].']	N/A	N/A	[('CL_0002486', 'strial intermediate cell', 13, 'intestinal epithelial cells'), ('UBERON_0001277', 'intestinal epithelium', 13, 'intestinal epithelial'), ('CL_0000990', 'conventional dendritic cell', 68, 'DCs'), ('UBERON_0000323', 'late embryo', 79, 'gut lamina propria'), ('GO_0007249', 'I-kappaB kinase/NF-kappaB signaling', 108, 'IgA class switching'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 108, 'IgA'), ('CL_0000236', 'B cell', 137, 'B cells')]
PMC4161853	8/2014	S240-PMC4161853	['also, Mz B Cells do not circulate in Mice, while they do in Humans.']	N/A	N/A	[('CL_0000485', 'mucosal type mast cell', 6, 'MZ'), ('CL_0000236', 'B cell', 9, 'B cells'), ('NCBITaxon_10088', 'Mus <genus>', 37, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 60, 'humans')]
PMC4169551	9/2014	S196-PMC4169551	['Tgfβ1 cooperates with Cd40 ligand, a tumour necrosis factor (tnf) family member Expressed by Cd4+ T Cells, to trigger iga class-switch dna recombination and generate Antigen-specific Iga+ B Cells[44].']	N/A	N/A	[('PR_000000046', 'TGF-beta', 0, 'TGFβ1'), ('PR_000001309', 'CD70 molecule', 22, 'CD40'), ('GO_0010467', 'gene expression', 80, 'expressed'), ('CL_0000251', 'extramedullary cell', 93, 'CD4'), ('PR_000001204', 'C-C chemokine receptor type 8', 93, 'CD4'), ('CL_0000084', 'T cell', 98, 'T cells'), ('CHEBI_59132', 'antigen', 166, 'antigen'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 183, 'IgA'), ('CL_0000236', 'B cell', 188, 'B cells')]
PMC4169551	9/2014	S227-PMC4169551	['moreover, colonization with lactobacilli , increased with Prebiotic incorporation in the diet as well, improved the numbers of Iga+ B Cells in Intestinal Mucosa[56].']	N/A	N/A	[('CHEBI_35293', 'fused compound', 58, 'prebiotic'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 127, 'IgA'), ('CL_0000236', 'B cell', 132, 'B cells'), ('UBERON_0001242', 'intestinal mucosa', 143, 'intestinal mucosa')]
PMC4203464	10/2014	S159-PMC4203464	['in addition, Dcs transport bacteria to the Mesenteric Lymph Nodes where B Cells recognize epitopes and become Iga-Secreting Plasma Cells specific to the Microbes.']	N/A	N/A	[('CL_0000990', 'conventional dendritic cell', 13, 'DCs'), ('UBERON_0002509', 'mesenteric lymph node', 43, 'mesenteric lymph nodes'), ('CL_0000236', 'B cell', 72, 'B cells'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 110, 'IgA'), ('CL_0000595', 'enucleate erythrocyte', 114, 'secreting'), ('GO_0046903', 'secretion', 114, 'secreting'), ('CL_0000786', 'plasma cell', 124, 'plasma cells'), ('UBERON_0001969', 'blood plasma', 124, 'plasma'), ('NCBITaxon_10088', 'Mus <genus>', 153, 'microbes')]
PMC4213680	12/2014	S22-PMC4213680	['the ratio of pro-apoptotic factor Bcl-2 Associated x Protein (Bax) and anti-apoptotic factor B Cell Lymphoma/Leukemia-2 (Bcl-2) serves as a good marker for Ovarian Follicle Apoptosis (rucker et al., 2000).']	N/A	N/A	[('PR_000027209', 'caveolin-1 isoform 1', 34, 'bcl-2 associated'), ('PR_000004253', 'Rho guanine nucleotide exchange factor 18', 53, 'protein'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 62, 'BAX'), ('CL_0000236', 'B cell', 93, 'B cell'), ('PR_000004699', 'B-cell lymphoma 3 protein', 93, 'B cell lymphoma/leukemia-2'), ('PR_000002304', 'apoptosis regulator BAX isoform 6', 121, 'Bcl-2'), ('UBERON_0001305', 'ovarian follicle', 156, 'ovarian follicle'), ('GO_0006915', 'apoptotic process', 173, 'apoptosis')]
PMC4263713	12/2014	S7-PMC4263713	['additionally, Vitamin A supplementation during late Gestation increased the numbers of Cd8+Intestinal Intraepithelial lymphocytes and decreased the numbers of B Lymphocytes in the Mesenteric Lymph Nodes.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('GO_0007565', 'female pregnancy', 52, 'gestation'), ('PR_000005170', 'CD37 molecule', 87, 'CD8'), ('UBERON_0000160', 'intestine', 91, 'intestinal'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 102, 'intraepithelial'), ('CL_0000236', 'B cell', 159, 'B lymphocytes'), ('UBERON_0002509', 'mesenteric lymph node', 180, 'mesenteric lymph nodes')]
PMC4263713	12/2014	S13-PMC4263713	['ra also enhances the Expression of Polymeric Immunoglobulin receptor (pigr)[4]and the Differentiation Of Iga Antibody-Secreting Cells (iga-asc) in Mice and Humans as well as stimulates the migration of T and B Cells to the Gut[5]–[9].']	N/A	N/A	[('GO_0010467', 'gene expression', 21, 'expression'), ('CHEBI_33839', 'macromolecule', 35, 'polymeric'), ('CHEBI_38709', '1,2-dicarboxyethanethiolate', 45, 'immunoglobulin'), ('GO_0019814', 'immunoglobulin complex', 45, 'immunoglobulin'), ('GO_0030154', 'cell differentiation', 86, 'differentiation of ... -secreting cells'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 105, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 109, 'antibody'), ('CL_0002200', 'oxyphil cell of thyroid', 128, '... cells'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 156, 'humans'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 202, 'T ...'), ('CL_0000236', 'B cell', 208, 'B cells'), ('UBERON_0001555', 'digestive tract', 223, 'gut')]
PMC4263713	12/2014	S78-PMC4263713	['flow cytometry\nthe monoclonal Antibodies pecy5-anti-Cd45, apc-anti-cd3, pe-anti-Cd4, Fitc-anti-Cd8 and Fitc-anti-Cd25 were used to label the T Lymphocytes, and pecy5-anti-Cd45 and Fitc-anti-Cd45R (bd pharmingen, san diego, ca) were used to label the B Lymphocytes.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 30, 'antibodies'), ('PR_000001309', 'CD70 molecule', 52, 'CD45'), ('PR_000001204', 'C-C chemokine receptor type 8', 80, 'CD4'), ('CHEBI_37926', 'fluorescein isothiocyanate', 85, 'FITC'), ('PR_000005170', 'CD37 molecule', 95, 'CD8'), ('CHEBI_37926', 'fluorescein isothiocyanate', 103, 'FITC'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 113, 'CD25'), ('CL_0000084', 'T cell', 141, 'T lymphocytes'), ('PR_000001309', 'CD70 molecule', 171, 'CD45'), ('CHEBI_37926', 'fluorescein isothiocyanate', 180, 'FITC'), ('PR_000001200', 'C-C chemokine receptor type 4', 190, 'CD45R'), ('CL_0000236', 'B cell', 250, 'B lymphocytes')]
PMC4263713	12/2014	S149-PMC4263713	['b) the numbers of Cd45R+B Cells were significantly lower in the Rats in the combined vasp and vas1 groups compared with the Rats in the vad group.']	N/A	N/A	[('PR_000001200', 'C-C chemokine receptor type 4', 18, 'CD45R'), ('CL_0000236', 'B cell', 24, 'B cells'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 64, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 124, 'rats')]
PMC4263713	12/2014	S241-PMC4263713	['ra is synthesized locally in Intestinal Dcs that up-regulate the levels of α4β7 and Ccr9 to promote T and B Cell Activation and Migration To the Intestine[31],[32].']	N/A	N/A	[('UBERON_0000160', 'intestine', 29, 'intestinal'), ('CL_0000990', 'conventional dendritic cell', 40, 'DCs'), ('PR_000001204', 'C-C chemokine receptor type 8', 84, 'CCR9'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 100, 'T ...'), ('GO_0019287', 'isopentenyl diphosphate biosynthetic process, mevalonate pathway', 100, 'T ... cell activation ... migration to ... intestine'), ('CL_0000236', 'B cell', 106, 'B cell'), ('UBERON_0000160', 'intestine', 145, 'intestine')]
PMC4263713	12/2014	S261-PMC4263713	['vas also decreases the percentage of B Cells in the Mlns and the number of Tcrγδ+iels.']	N/A	N/A	[('CL_0000236', 'B cell', 37, 'B cells'), ('UBERON_0001791', 'inner nuclear layer of retina', 52, 'MLNs'), ('PR_000016190', 'trichohyalin-like protein 1', 75, 'TCRγδ')]
PMC4271720	12/2014	S175-PMC4271720	['it is characterized by Microvascular dysfunction, progressive fibrosis of skin and/or internal Organs, and Immune abnormalities in Microvascular Endothelial Cells, T Lymphocytes, B Lymphocytes, and Fibroblasts.']	N/A	N/A	[('GO_0005874', 'microtubule', 23, 'microvascular'), ('UBERON_0000062', 'organ', 95, 'organs'), ('UBERON_0002405', 'immune system', 107, 'immune'), ('CL_0000129', 'microglial cell', 131, 'microvascular'), ('CL_0000115', 'endothelial cell', 145, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 145, 'endothelial'), ('CL_0000084', 'T cell', 164, 'T lymphocytes'), ('CL_0000236', 'B cell', 179, 'B lymphocytes'), ('CL_0000057', 'fibroblast', 198, 'fibroblasts')]
PMC4271720	12/2014	S177-PMC4271720	['as the microvascular injury leads to Endothelial Activation, Leukocytes are recruited and leads to T and B Lymphocytes to Secrete a Cocktail of cytokines, chemokines, and Autoantibodies.']	N/A	N/A	[('GO_0001713', 'ectodermal cell fate determination', 37, 'endothelial activation'), ('UBERON_0001986', 'endothelium', 37, 'endothelial'), ('CL_0000738', 'leukocyte', 61, 'leukocytes'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 99, 'T ...'), ('CL_0000236', 'B cell', 105, 'B lymphocytes'), ('GO_0046903', 'secretion', 122, 'secrete'), ('CHEBI_60004', 'mixture', 132, 'cocktail'), ('GO_0044308', 'axonal spine', 171, 'autoantibodies')]
PMC4284764	12/2014	S140-PMC4284764	["the fold-increase of the experimental sample relative to the control was calculated using the formula 2−δδ c t.ijms-15-23255-t005_table 5\n\ncaption (table-wrap): table 5\n\nqpcr Primers sequences.geneforwardreverse Bcl6 5'-ctgagggaaggcaacatcat-3'5'-cggctgttcaggaactcttc-3' Egr1 5'-caggagtgatgaacgcaaga-3'5'-agcccggagaggagtaagag-3' olr1668 5'-acgtggctatctgcagacct-3'5'-ctccccacaggcagttttta-3' Sgk1 5'-gggctgtcttgtatgagatgc-3'5'-gtgccttgctgagttggag-3' Dmrtc1C 5'-acatacaagtcacgctggca-3'5'-ttggcctgtttgaggggttt-3' r18s 5'-gccgcggtaattccagctcca-3'5'-cccgcccgctcccaagatc-3'\nBcl6 = B-Cell Cll/Lymphoma 6; Egr1 = Early Growth Response-1; olr1668 = Olfactory receptor 1668; Sgk1 = Serum and Glucocorticoid-Regulated Kinase 1; Dmrtc1C = Dmrt-Like Family C1C1."]	N/A	N/A	[('SO_0000112', 'primer', 175, 'primers'), ('PR_000004689', 'B-cell lymphoma/leukemia 10', 212, 'Bcl6'), ('PR_000006903', 'elongation factor 1-alpha 1', 270, 'Egr1'), ('PR_000000364', 'smad2', 389, 'Sgk1'), ('PR_000006602', 'dynamin-1-like protein', 447, 'Dmrtc1c'), ('PR_000004689', 'B-cell lymphoma/leukemia 10', 566, 'Bcl6'), ('CL_0000236', 'B cell', 573, 'B-cell'), ('PR_000004699', 'B-cell lymphoma 3 protein', 573, 'B-cell CLL'), ('PR_000009999', 'lysozyme g-like protein 1', 584, 'lymphoma 6'), ('PR_000006903', 'elongation factor 1-alpha 1', 596, 'Egr1'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 603, 'early growth response-1'), ('GO_0007608', 'sensory perception of smell', 638, 'olfactory'), ('PR_000000364', 'smad2', 663, 'Sgk1'), ('PR_000014750', 'serine/arginine-rich splicing factor 11', 670, 'serum'), ('UBERON_0001977', 'blood serum', 670, 'serum'), ('CHEBI_24261', 'glucocorticoid', 680, 'glucocorticoid'), ('PR_000007877', 'guanylate-binding protein 4', 680, 'glucocorticoid-regulated kinase 1'), ('GO_0065007', 'biological regulation', 695, 'regulated'), ('PR_000006602', 'dynamin-1-like protein', 715, 'Dmrtc1c'), ('PR_000029438', 'EF-hand calcium-binding domain-containing protein 5', 725, 'DMRT-like family C1c1')]
PMC4302429	1/2015	S164-PMC4302429	['for example, Activated Human T- and B-Cells can convert the inactive intermediate of Vitamin D (also known as 25-Hydroxyvitamin D or 25(Oh)D) to active 1,25(Oh)2D in vitro [35], and this locally produced 1,25(Oh)2D acts on Immune Cells in an autocrine or Paracrine fashion [36].']	N/A	N/A	[('CL_0002627', 'mature astrocyte', 13, 'activated'), ('NCBITaxon_9606', 'Homo sapiens', 23, 'human'), ('CL_0000918', 'Tc2 cell', 29, 'T- ...'), ('CL_0000236', 'B cell', 36, 'B-cells'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 110, '25-hydroxyvitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 136, 'OH)D'), ('CHEBI_82784', 'PVP38-Ag NP', 152, '1,25(OH)2D'), ('CHEBI_82784', 'PVP38-Ag NP', 204, '1,25(OH)2D'), ('CL_0000738', 'leukocyte', 223, 'immune cells'), ('UBERON_0002405', 'immune system', 223, 'immune'), ('GO_0038001', 'paracrine signaling', 255, 'paracrine')]
PMC4354412	3/2015	S32-PMC4354412	['in vitro , Scd14 induces B-Cell growth and Differentiation independently of Activated T Cells (18).']	N/A	N/A	[('PR_000002097', 'sodium channel protein type 11 subunit alpha', 11, 'sCD14'), ('CL_0000236', 'B cell', 25, 'B-cell'), ('GO_0030154', 'cell differentiation', 27, 'cell ... differentiation'), ('CL_0002129', 'regular atrial cardiac myocyte', 76, 'activated T cells')]
PMC4372177	2/2015	S264-PMC4372177	['this method estimated the proportions of six cell types (Monocytes, Granulocytes, Cd8+ T-Cells, Cd4+ T-Cells, Nk Cells, and B Cells) for each Individual based on their Genome-wide methylation signatures, using an external reference inferred from sample profiles of cell-specific methylation [125].']	N/A	N/A	[('CL_0000576', 'monocyte', 57, 'monocytes'), ('CL_0000094', 'granulocyte', 68, 'granulocytes'), ('PR_000005170', 'CD37 molecule', 82, 'CD8'), ('CL_0000084', 'T cell', 87, 'T-cells'), ('PR_000001204', 'C-C chemokine receptor type 8', 96, 'CD4'), ('CL_0000084', 'T cell', 101, 'T-cells'), ('CL_0000623', 'natural killer cell', 110, 'NK cells'), ('CL_0000236', 'B cell', 124, 'B cells'), ('NCBITaxon_1', 'root', 142, 'individual'), ('SO_0001026', 'genome', 168, 'genome')]
PMC4448820	5/2015	S223-PMC4448820	['this locally generated atra imparts Gut homing specificity to T and B Cells.']	N/A	N/A	[('UBERON_0001555', 'digestive tract', 36, 'gut'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 62, 'T ...'), ('CL_0000236', 'B cell', 68, 'B cells')]
PMC4448820	5/2015	S252-PMC4448820	['● vad causes reduced Trafficking Of T and B Cells to Tissues (158,166,167).']	N/A	N/A	[('GO_0051337', 'amitosis', 21, 'trafficking of ... cells'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 36, 'T ...'), ('CL_0000236', 'B cell', 42, 'B cells'), ('UBERON_0000479', 'tissue', 53, 'tissues')]
PMC4448820	5/2015	S678-PMC4448820	['id inhibits the Proliferation Of T Lymphocytes and, to a lesser extent, B Lymphocytes (359).']	N/A	N/A	[('GO_0001783', 'B cell apoptotic process', 16, 'proliferation of T lymphocytes'), ('CL_0000084', 'T cell', 33, 'T lymphocytes'), ('CL_0000236', 'B cell', 72, 'B lymphocytes'), ('GO_0040011', 'locomotion', 74, 'lymphocytes')]
PMC4514967	12/2014	S72-PMC4514967	['ra promotes the upregulation of the Gut homing receptors Ccr9 and Α4Β7Integrin on B Cells and aids in the Generation Of Iga+B Cells.']	N/A	N/A	[('UBERON_0001555', 'digestive tract', 36, 'gut'), ('PR_000001204', 'C-C chemokine receptor type 8', 57, 'CCR9'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 66, 'α4β7integrin'), ('CL_0000236', 'B cell', 82, 'B cells'), ('GO_0007567', 'parturition', 84, 'cells'), ('GO_0002007', 'detection of hypoxic conditions in blood by chemoreceptor signaling', 106, 'generation of IgA ... B cells'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 120, 'IgA'), ('CL_0000236', 'B cell', 124, 'B cells')]
PMC4588865	8/2015	S67-PMC4588865	['cell-type proportions were estimated using the estimatecellcounts function in the minfi r package,35which is based on the method developed by houseman.36this estimated the proportion of B Cells, cd8 T Cells, cd4 Tcells, Granulocytes, Nk Cells and Monocytes in each sample.']	N/A	N/A	[('CL_0000236', 'B cell', 186, 'B cells'), ('CL_0000084', 'T cell', 199, 'T cells'), ('CL_0000084', 'T cell', 212, 'Tcells'), ('CL_0000094', 'granulocyte', 220, 'granulocytes'), ('CL_0000623', 'natural killer cell', 234, 'NK cells'), ('GO_0005634', 'nucleus', 234, 'NK'), ('CL_0000576', 'monocyte', 247, 'monocytes')]
PMC4703052	1/2016	S49-PMC4703052	['T and B Lymphocytes are the central cellular mediators of specific immunity, and an exposure-driven, darwinian process of clonal selection is necessary for the development of Acquired immunity.']	N/A	N/A	[('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 0, 'T ...'), ('CL_0000236', 'B cell', 6, 'B lymphocytes'), ('GO_0007605', 'sensory perception of sound', 175, 'acquired')]
PMC4703052	1/2016	S50-PMC4703052	['mature T and B Lymphocytes Express unique Antigenic receptors, the functional form of which results from the random rearrangement of Mini-Gene Segments, imprecise joining of nucleotide sequences, and random combinations of peptide chains.']	N/A	N/A	[('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 7, 'T ...'), ('CL_0000236', 'B cell', 13, 'B lymphocytes'), ('GO_0010467', 'gene expression', 27, 'express'), ('CHEBI_59132', 'antigen', 42, 'antigenic'), ('SO_0000863', 'mRNA_attribute', 133, 'mini-gene segments')]
PMC4703052	1/2016	S53-PMC4703052	['with a diverse pool of T and B Lymphocytes in place, Antigenic exposures drive the maturation of acquired Immune defenses by binding to, and activating, specific Lymphocytes with matching receptors.']	N/A	N/A	[('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 23, 'T ...'), ('CL_0000236', 'B cell', 29, 'B lymphocytes'), ('CHEBI_59132', 'antigen', 53, 'antigenic'), ('UBERON_0002405', 'immune system', 106, 'immune'), ('CL_0000542', 'lymphocyte', 162, 'lymphocytes')]
PMC4703052	1/2016	S69-PMC4703052	['Amino Acids, Lipids) to fuel the generation of a large pool of T and B Lymphocytes with diverse Antigen binding specificities.']	N/A	N/A	[('CHEBI_33867', 'idonates', 0, 'amino acids'), ('CHEBI_18059', 'lipid', 13, 'lipids'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 63, 'T ...'), ('CL_0000236', 'B cell', 69, 'B lymphocytes'), ('CHEBI_59132', 'antigen', 96, 'antigen')]
PMC4703052	1/2016	S95-PMC4703052	['for example, infants receiving a vaccine against bacterial meningitis mounted a primary response which included, on average, the production of 11 Memory B Cells per 106total Lymphocytes and 19.8 μg/ml Igg Antibodies, both specific to the Antigen in the vaccine [46].']	N/A	N/A	[('CL_0000313', 'serous secreting cell', 146, 'memory'), ('GO_0007613', 'memory', 146, 'memory B cells'), ('CL_0000236', 'B cell', 153, 'B cells'), ('CL_0000542', 'lymphocyte', 174, 'lymphocytes'), ('GO_0071735', 'IgG immunoglobulin complex', 201, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 205, 'antibodies'), ('CHEBI_59132', 'antigen', 238, 'antigen')]
PMC4703052	1/2016	S97-PMC4703052	['a rapid and robust response is a defining feature of Immunological Memory, and in this case the production of key Effectors—Antigen-specific Antibodies and B Lymphocytes—was 2.3–3.6 times greater following secondary exposure.']	N/A	N/A	[('GO_0007566', 'embryo implantation', 53, 'immunological'), ('GO_0007613', 'memory', 67, 'memory'), ('CHEBI_35224', 'effector', 114, 'effectors'), ('CHEBI_59132', 'antigen', 124, 'antigen'), ('GO_0042571', 'immunoglobulin complex, circulating', 141, 'antibodies'), ('CL_0000236', 'B cell', 156, 'B lymphocytes')]
PMC4703052	1/2016	S104-PMC4703052	['consideration of B Lymphocyte Proliferation following secondary exposure paints a similar picture.']	N/A	N/A	[('CL_0000236', 'B cell', 17, 'B lymphocyte'), ('GO_0042100', 'B cell proliferation', 17, 'B lymphocyte proliferation')]
PMC4703052	1/2016	S105-PMC4703052	['the increase in Memory B Lymphocytes from 11 to 40 per 106lymphocytes translates into a total of 72 500 additional Cells In Circulation, which represents only 0.0029% of the total Lymphocyte pool.']	N/A	N/A	[('GO_0007613', 'memory', 16, 'memory'), ('CL_0000236', 'B cell', 23, 'B lymphocytes'), ('CL_0000080', 'circulating cell', 115, 'cells in circulation'), ('CL_0000542', 'lymphocyte', 180, 'lymphocyte')]
PMC4703052	1/2016	S177-PMC4703052	['pathogen exposure\non a mechanical level, Antigen exposures drive the selection of specific cell lines, which define the mature pool of T and B Lymphocytes.']	N/A	N/A	[('CHEBI_59132', 'antigen', 41, 'antigen'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 135, 'T ...'), ('CL_0000236', 'B cell', 141, 'B lymphocytes')]
PMC4829940	5/2016	S66-PMC4829940	['in the primary analysis, the models were adjusted for maternal pre-Pregnancy body mass index (bmi, continuous), offspring sex, maternal education (4 categories), maternal smoking (yes/no), maternal Folate Plasma values (continuous), parity (3 categories), maternal age (continuous), Birth season (four categories) and estimated cell type proportions (continuous matrix consisting of 6 (default) Blood Cell-types: Cd4+T Cells, Cd8+T Cells, Nk-Cells, B-Cells, Monocytes and Granulocytes).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 198, 'folate'), ('UBERON_0001969', 'blood plasma', 205, 'plasma'), ('GO_0007567', 'parturition', 283, 'birth'), ('CL_0000081', 'blood cell', 395, 'blood cell'), ('UBERON_0000178', 'blood', 395, 'blood'), ('CL_0000476', 'thyrotroph', 413, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 413, 'CD4'), ('CL_0000084', 'T cell', 417, 'T cells'), ('CL_0002038', 'T follicular helper cell', 426, 'CD8'), ('PR_000005170', 'CD37 molecule', 426, 'CD8'), ('CL_0000084', 'T cell', 430, 'T cells'), ('CL_0000623', 'natural killer cell', 439, 'NK-cells'), ('GO_0071561', 'nucleus-vacuole junction', 439, 'NK-'), ('CL_0000236', 'B cell', 449, 'B-cells'), ('CL_0000576', 'monocyte', 458, 'monocytes'), ('CL_0000094', 'granulocyte', 472, 'granulocytes')]
PMC4896250	4/2016	S65-PMC4896250	['the co-Expression of cd3 and Bcl-6 markers identified tfhcells close to Bcl-6+B Cells with the typical formation of germinal centers.']	N/A	N/A	[('GO_0010467', 'gene expression', 7, 'expression'), ('PR_000004592', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2', 29, 'Bcl-6'), ('GO_0005854', 'nascent polypeptide-associated complex', 32, '-'), ('PR_000004592', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2', 72, 'Bcl-6'), ('GO_0005657', 'replication fork', 76, '6'), ('CL_0000236', 'B cell', 78, 'B cells')]
PMC4896250	4/2016	S3197-PMC4896250	['in addition, Cd19+ B-Lymphocytes (12.6± 4.9 vs 8.9± 3.2%) and Cd4+ Cd25+ cells (13.6± 4.6 vs 7.7± 3.8%) counts in Peripheral Blood were increased parallel with increased Dap exposure levels (p= 0.035 and p= 0.004, respectively).']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 13, 'CD19'), ('CL_0000236', 'B cell', 19, 'B-lymphocytes'), ('PR_000001204', 'C-C chemokine receptor type 8', 62, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 67, 'CD25'), ('UBERON_0012101', 'perinatal stage', 114, 'peripheral blood'), ('CHEBI_4450', 'desmopressin', 170, 'DAP')]
PMC4896250	4/2016	S3335-PMC4896250	['t-Msc treatment reduced th2 cytokines and ova specific Ige secretion from B Cells.']	N/A	N/A	[('CL_0000186', 'myofibroblast cell', 2, 'MSC'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 55, 'IgE'), ('CL_0000236', 'B cell', 74, 'B cells')]
PMC4896250	4/2016	S4605-PMC4896250	['a326 continuous B Cell Stimulation with Cd40 ligand induce Ige isotype switching\n\nsejin an1, jae ho lee2\n\n1chungnam national university hospital;2chungnam national university school of medicine, south korea\n\ncorrespondence: jae ho lee – chungnam national university school of medicine, south korea\nbackground: in the T and B Cells interaction, Activated Helper T(Th) Cell can stimulate Small B Cells by the manner of direct physiologic contact each other.']	N/A	N/A	[('CL_0000969', 'regulatory B cell', 16, 'B Cell'), ('GO_0031296', 'B cell costimulation', 16, 'B Cell Stimulation'), ('PR_000001309', 'CD70 molecule', 40, 'CD40'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 59, 'IgE'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 317, 'T ...'), ('CL_0000236', 'B cell', 323, 'B cells'), ('CL_0002627', 'mature astrocyte', 344, 'activated'), ('CL_0000912', 'helper T cell', 354, 'helper T ...'), ('CL_0000545', 'T-helper 1 cell', 363, 'Th) cell'), ('CL_0000485', 'mucosal type mast cell', 386, 'small'), ('CL_0000236', 'B cell', 392, 'B cells')]
PMC4896250	4/2016	S4606-PMC4896250	['the Cd40 ligand(Cd40L) Molecules Expressed on the Surface Membrane Of Activated Th Cells stimulate B Cells after binding with bind with B Cells.']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 4, 'CD40'), ('PR_000001309', 'CD70 molecule', 16, 'CD40L'), ('CHEBI_36357', 'polyatomic entity', 23, 'molecules'), ('GO_0010467', 'gene expression', 33, 'expressed'), ('GO_0016935', 'glycine-gated chloride channel complex', 50, 'surface membrane of ... cells'), ('CL_0002629', 'mature microglial cell', 70, 'activated Th cells'), ('CL_0000236', 'B cell', 99, 'B cells'), ('CL_0000236', 'B cell', 136, 'B cells')]
PMC4896250	4/2016	S4607-PMC4896250	['the Activated B Cells Proliferate and differentiate to Secrete Immunoglobulin Igm, igg1 and ige in the presence of lymphokines.']	N/A	N/A	[('CL_0002627', 'mature astrocyte', 4, 'activated'), ('CL_0000236', 'B cell', 14, 'B cells'), ('GO_0008283', 'cell proliferation', 22, 'proliferate'), ('GO_0046903', 'secretion', 55, 'secrete'), ('GO_0019814', 'immunoglobulin complex', 63, 'immunoglobulin'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 78, 'IgM')]
PMC4896250	4/2016	S4609-PMC4896250	['B Cells were incubated with Plasma Membranes and various cytokines in the round bottomed 96 well plate for various periods of time and B Cells were pulsed and harvested to check the Dna Synthesis Of B Cells.']	N/A	N/A	[('CL_0000236', 'B cell', 0, 'B cells'), ('GO_0005886', 'plasma membrane', 28, 'plasma membranes'), ('CL_0000236', 'B cell', 135, 'B cells'), ('GO_0051403', 'stress-activated MAPK cascade', 182, 'DNA synthesis of ... cells'), ('CL_0000236', 'B cell', 199, 'B cells')]
PMC4896250	4/2016	S4610-PMC4896250	['the B Cell culture supernatants were assayed for Igm, igg1, and Ige by using isotype specific sandwich elisa.']	N/A	N/A	[('CL_0000236', 'B cell', 4, 'B cell'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 49, 'IgM'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 64, 'IgE')]
PMC4896250	4/2016	S4611-PMC4896250	['results: in the kinetics of B Cell Proliferation, B Cell Proliferation was peak at day 4 in the presence of Interleukin(Il)-4.']	N/A	N/A	[('CL_0000236', 'B cell', 28, 'B cell'), ('GO_0008283', 'cell proliferation', 30, 'cell proliferation'), ('CL_0000236', 'B cell', 50, 'B cell'), ('GO_0008283', 'cell proliferation', 52, 'cell proliferation'), ('PR_000001470', 'interleukin-28B', 108, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 120, 'IL)-4')]
PMC4896250	4/2016	S4612-PMC4896250	['in the Immunoglobuline synthesis, Plasma Membrane Activated B Cells Secreted Igm, igg1, and Ige serially in the presence of th2 type lymphokines.']	N/A	N/A	[('GO_0042580', 'mannosome', 7, 'immunoglobuline'), ('GO_0005886', 'plasma membrane', 34, 'plasma membrane'), ('CL_0002627', 'mature astrocyte', 50, 'activated'), ('CL_0000236', 'B cell', 60, 'B cells'), ('GO_0046903', 'secretion', 68, 'secreted'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 77, 'IgM'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 92, 'IgE')]
PMC4896250	4/2016	S4615-PMC4896250	['the Il-4 and Il-5 are required to Proliferate B Cells and induce Igm, and isotype switching to Secrete Igg1 and Ige.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 4, 'IL-4'), ('PR_000001470', 'interleukin-28B', 13, 'IL-5'), ('GO_0008283', 'cell proliferation', 34, 'proliferate'), ('CL_0000236', 'B cell', 46, 'B cells'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 65, 'IgM'), ('GO_0046903', 'secretion', 95, 'secrete'), ('GO_0071735', 'IgG immunoglobulin complex', 103, 'IgG1'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 112, 'IgE')]
PMC4896250	4/2016	S5049-PMC4896250	['cell suspension was stained with Fluorophore labeled Antibodies to determine Il-33 Intracellular Expression in Cd45+3+T Cells, Cd45+19+B Cells, Cd45+cd3-Cd19-ly-6G-cells, Cd45-324+Epithelial Cells by flow cytometry.']	N/A	N/A	[('CHEBI_51217', 'fluorochrome', 33, 'fluorophore'), ('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibodies'), ('PR_000001470', 'interleukin-28B', 77, 'IL-33'), ('GO_0005622', 'intracellular anatomical structure', 83, 'intracellular'), ('GO_0010467', 'gene expression', 97, 'expression'), ('PR_000001309', 'CD70 molecule', 111, 'CD45'), ('CL_0000084', 'T cell', 118, 'T cells'), ('PR_000001309', 'CD70 molecule', 127, 'CD45'), ('CL_0000236', 'B cell', 135, 'B cells'), ('PR_000001309', 'CD70 molecule', 144, 'CD45'), ('PR_000001309', 'CD70 molecule', 153, 'CD19'), ('PR_000007090', 'glycerophosphocholine cholinephosphodiesterase ENPP6', 161, '6G'), ('PR_000001309', 'CD70 molecule', 171, 'CD45'), ('CL_0000066', 'epithelial cell', 180, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 180, 'epithelial')]
PMC4896250	4/2016	S7966-PMC4896250	['these clusters were mainly composed of B Cells, and were characterized by area of B220+and Cd21+cells, that is inducible Bronchus-associated lymphoid tissue (ibalt).']	N/A	N/A	[('CL_0000236', 'B cell', 39, 'B cells'), ('PR_000004691', 'B-cell lymphoma/leukemia 11B', 82, 'B220'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 91, 'CD21'), ('UBERON_0002185', 'bronchus', 121, 'bronchus')]
PMC4979151	8/2016	S39-PMC4979151	['the non-adherent Lymphocytes, which consisted predominantly of 70–75\xa0% of T Lymphocyte (cd3), 20–23\xa0% of B Lymphocytes (Cd19) and 5–7\xa0% of Natural Killer Cells (cd16) were separated from adherent Monocytes (cd14) (10–15\xa0% in total cbmc), and cultured in presence of stimulants (T Cell Mitogen phytohemagglutinin (Pha) or agonistic Antibodies to T-Cell receptor).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 17, 'lymphocytes'), ('CL_0000084', 'T cell', 74, 'T lymphocyte'), ('CL_0000236', 'B cell', 105, 'B lymphocytes'), ('PR_000001309', 'CD70 molecule', 120, 'CD19'), ('CL_0000623', 'natural killer cell', 139, 'Natural killer cells'), ('CL_0000576', 'monocyte', 196, 'monocytes'), ('CL_0000084', 'T cell', 278, 'T cell'), ('CHEBI_52290', 'mitogen', 285, 'mitogen'), ('CHEBI_34926', 'Pitrazepin', 313, 'PHA'), ('GO_0042571', 'immunoglobulin complex, circulating', 331, 'antibodies'), ('CL_0000084', 'T cell', 345, 'T-cell'), ('GO_0005622', 'intracellular anatomical structure', 346, '-cell')]
PMC4979151	8/2016	S52-PMC4979151	['T and B Cell Activation pathway\nextractions of mrna from both pha-stimulated and Unstimulated Lymphocytes were performed using rneasy mini kit according to the manufacturer’s instructions (qiagen gmbh, hilden, germany).']	N/A	N/A	[('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 0, 'T ...'), ('GO_0050909', 'sensory perception of taste', 0, 'T ...'), ('CL_0000236', 'B cell', 6, 'B cell'), ('GO_0042113', 'B cell activation', 6, 'B cell activation'), ('GO_0048061', 'positive gravitaxis', 81, 'unstimulated'), ('CL_0000542', 'lymphocyte', 94, 'lymphocytes')]
PMC4979151	8/2016	S96-PMC4979151	['Prenatal Vitamin D supplementation and T and B Cell Activation pathways\nwithin each intervention group, comparisons were made between Genes from unstimulated and Stimulated Lymphocytes.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 39, 'T ...'), ('GO_0050909', 'sensory perception of taste', 39, 'T ...'), ('CL_0000236', 'B cell', 45, 'B cell'), ('GO_0042113', 'B cell activation', 45, 'B cell activation'), ('SO_0000704', 'gene', 134, 'genes'), ('CL_0002651', 'endothelial cell of venous sinus of spleen', 162, 'stimulated'), ('CL_0000542', 'lymphocyte', 173, 'lymphocytes')]
PMC4979151	8/2016	S105-PMC4979151	['among 84 Genes of T and B Cell Pathway.']	N/A	N/A	[('SO_0000704', 'gene', 9, 'genes'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 18, 'T ...'), ('GO_0050909', 'sensory perception of taste', 18, 'T ...'), ('CL_0000236', 'B cell', 24, 'B cell'), ('GO_0002773', 'B cell inhibitory signaling pathway', 24, 'B cell pathway')]
PMC4979151	8/2016	S124-PMC4979151	['active Vitamin D can inhibit in vitro Proliferation and Differentiation Of B Cells into Plasma Cells as well as Antibody Production [23,24].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 56, 'differentiation of ... cells ... cells'), ('CL_0000236', 'B cell', 75, 'B cells'), ('CL_0000786', 'plasma cell', 88, 'plasma cells'), ('GO_0002376', 'immune system process', 112, 'antibody production'), ('GO_0042571', 'immunoglobulin complex, circulating', 112, 'antibody')]
PMC4997411	8/2016	S7-PMC4997411	['maternal hfd increased the Inhibitor of the Apoptosis-Related Gene Of B-Cell Lymphoma-2 ( bcl2 ) mrna Expression at g90 and d160, whereas, pro-apoptotic-related Gene Bcl -2 assaciated x protein ( bax ) was reduced.']	N/A	N/A	[('CHEBI_35222', 'inhibitor', 27, 'inhibitor'), ('GO_0006915', 'apoptotic process', 44, 'apoptosis'), ('PR_000003900', 'aldo-keto reductase family 1 member A1', 44, 'apoptosis-related gene of B-cell lymphoma-2'), ('SO_0000704', 'gene', 62, 'gene'), ('CL_0000236', 'B cell', 70, 'B-cell'), ('UBERON_0001790', 'outer plexiform layer of retina', 71, '-'), ('GO_0010467', 'gene expression', 102, 'expression'), ('SO_0000704', 'gene', 161, 'gene'), ('PR_000004591', 'beta-1,4-glucuronyltransferase 1', 166, 'bcl -2')]
PMC5161647	8/2016	S88-PMC5161647	['specifically, Igf2 Dna Methylation scores were residualized for estimated proportions of cells in whole Blood (proportion of Cd8+ T Cells, Cd4+ T Cells, natural Killer [Nk] Cells, B Cells, and Monocytes).']	N/A	N/A	[('PR_000008989', 'interleukin-1 family member 7', 14, 'IGF2'), ('GO_0006306', 'DNA methylation', 19, 'DNA methylation'), ('UBERON_0000178', 'blood', 104, 'blood'), ('CL_0000820', 'B-1a B cell', 125, 'CD8 ...'), ('PR_000005170', 'CD37 molecule', 125, 'CD8'), ('CL_0000084', 'T cell', 130, 'T cells'), ('CL_0000476', 'thyrotroph', 139, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 139, 'CD4'), ('CL_0000084', 'T cell', 144, 'T cells'), ('CL_0011107', 'Muller cell', 161, 'killer ...'), ('CL_0002280', 'type N enteroendocrine cell', 169, 'NK ... cells'), ('GO_0005634', 'nucleus', 169, 'NK'), ('CL_0000236', 'B cell', 180, 'B cells'), ('CL_0000576', 'monocyte', 193, 'monocytes')]
PMC5183755	12/2016	S61-PMC5183755	['estimated Blood Cell percentages and Naïve T Cell abundance\nin five illumina 450k datasets (datasets 6–10), we also considered the proportions of Cd8 T Cells, cd4 T Cells, Natural Killer Cells, and B Cells, and the abundance of defined different subtypes of T Cells: Naive T Cells = Cd45Ra+Ccr7+ and Memory T Cells = cd45ro+.']	N/A	N/A	[('CL_0000081', 'blood cell', 10, 'Blood Cell'), ('UBERON_0000178', 'blood', 10, 'Blood'), ('CL_0000898', 'naive T cell', 37, 'Naïve T cell'), ('CL_0000920', 'CD8-positive, CD28-negative, alpha-beta regulatory T cell', 146, 'CD8 T cells'), ('CL_0000084', 'T cell', 163, 'T cells'), ('CL_0000623', 'natural killer cell', 172, 'natural killer cells'), ('CL_0000236', 'B cell', 198, 'B cells'), ('CL_0000084', 'T cell', 258, 'T cells'), ('CL_0000898', 'naive T cell', 267, 'naive T cells'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 283, 'CD45RA'), ('PR_000001204', 'C-C chemokine receptor type 8', 290, 'CCR7'), ('CL_0000813', 'memory T cell', 300, 'memory T cells'), ('GO_0007613', 'memory', 300, 'memory')]
PMC5183755	12/2016	S82-PMC5183755	['Lymphocyte subsets were categorized according to following definitions: T Cells (cd3+), B Cells (Cd19+), Nk Cells (cd16+/Cd56+), naïve (Cd45Ra+Ccr7+Cd27+) Cd4+or Cd8+T Cells, and Memory (Cd45Ro+) Cd4+or Cd8+T Cells.']	N/A	N/A	[('CL_0000824', 'mature natural killer cell', 0, 'Lymphocyte'), ('CL_0000084', 'T cell', 72, 'T cells'), ('CL_0000236', 'B cell', 88, 'B cells'), ('PR_000001309', 'CD70 molecule', 97, 'CD19'), ('CL_0000623', 'natural killer cell', 105, 'NK cells'), ('GO_0005634', 'nucleus', 105, 'NK'), ('PR_000001309', 'CD70 molecule', 121, 'CD56'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 136, 'CD45RA'), ('PR_000001204', 'C-C chemokine receptor type 8', 143, 'CCR7'), ('PR_000001309', 'CD70 molecule', 148, 'CD27'), ('PR_000001204', 'C-C chemokine receptor type 8', 155, 'CD4'), ('PR_000005170', 'CD37 molecule', 162, 'CD8'), ('CL_0000084', 'T cell', 166, 'T cells'), ('GO_0007613', 'memory', 179, 'memory'), ('PR_000005170', 'CD37 molecule', 187, 'CD45RO'), ('PR_000001204', 'C-C chemokine receptor type 8', 196, 'CD4'), ('PR_000005170', 'CD37 molecule', 203, 'CD8'), ('CL_0000084', 'T cell', 207, 'T cells')]
PMC5183755	12/2016	S88-PMC5183755	['in five illumina 450k datasets (datasets 6–10), the epigenetic clock software also allowed us to determine the ordinal abundance measures, proportions of Cd8+ t cells, cd4+ T Cells, Natural Killer Cells (Nk Cells), and B Cells, and different subtypes of T Cells, Naive T Cells (cd45ra+Ccr7+) and Memory and Effector T Cells (Cd8+Cd28–Cd45Ra–).']	N/A	N/A	[('PR_000005170', 'CD37 molecule', 154, 'CD8'), ('CL_0000084', 'T cell', 173, 'T cells'), ('CL_0000623', 'natural killer cell', 182, 'natural killer cells'), ('CL_0000623', 'natural killer cell', 204, 'NK cells'), ('CL_0000236', 'B cell', 219, 'B cells'), ('CL_0000084', 'T cell', 254, 'T cells'), ('CL_0000898', 'naive T cell', 263, 'naive T cells'), ('PR_000001204', 'C-C chemokine receptor type 8', 285, 'CCR7'), ('CL_0000104', 'multipolar neuron', 296, 'memory ...'), ('GO_0007613', 'memory', 296, 'memory'), ('CL_0000911', 'effector T cell', 307, 'effector T cells'), ('PR_000005170', 'CD37 molecule', 325, 'CD8'), ('PR_000001309', 'CD70 molecule', 329, 'CD28'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 334, 'CD45RA')]
PMC5295525	6/2015	S55-PMC5295525	['caption (fig): figure 4\n\nLiver biopsy showing (a) photomicrograph of moderate to poorly differentiated angiosarcoma with dense clumps of plump and spindle shaped, Anaplastic cells focally showing slit-like vascular lumens (original magnification, × 200); (b) entrapped Hepatocytes (arrows) within the tumor (original magnification, × 400); (c) immunohistochemical staining for the Endothelial marker Cd34 demonstrating the Endothelial origin of the neoplastic cells.']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'Liver'), ('CL_0000236', 'B cell', 163, 'anaplastic'), ('CL_0000182', 'hepatocyte', 269, 'hepatocytes'), ('UBERON_0001986', 'endothelium', 381, 'endothelial'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 400, 'CD34'), ('UBERON_0001986', 'endothelium', 423, 'endothelial')]
PMC5941629	5/2018	S81-PMC5941629	['cell types included Cd8T, Cd4T, natural killer, B Lymphocytes, Monocytes, Granulocytes, and Nucleated Red Blood Cells.']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 20, 'CD8T'), ('PR_000001200', 'C-C chemokine receptor type 4', 26, 'CD4T'), ('CL_0000236', 'B cell', 48, 'B lymphocytes'), ('CL_0000576', 'monocyte', 63, 'Monocytes'), ('CL_0002062', 'type I pneumocyte', 74, 'Granulocytes'), ('CL_0002242', 'nucleate cell', 92, 'nucleated'), ('GO_0005634', 'nucleus', 92, 'nucleated'), ('CL_0000232', 'erythrocyte', 102, 'red blood cells'), ('UBERON_0000178', 'blood', 106, 'blood')]
